Eurowaset Tablets 10/5 mg

Adult dose

This medication is administered once daily, regardless of meals. For primary hypercholesterolemia, an initial dose of 10/5 mg once daily is recommended. If more significant reduction of LDL cholesterol is required, the dosage can be adjusted. After starting administration or adjusting the dose, lipid levels should be checked at intervals of at least 4 weeks, and dosages will be adjusted accordingly, with a maximum daily dose of 10/20 mg.

This medication can rarely cause severe muscle damage that may lead to kidney problems; therefore, if severe muscle pain or weakness occurs, immediate consultation with a physician is necessary. In particular, patients with severe infections, hypotension, major surgery or trauma, and serious metabolic abnormalities should stop or temporarily discontinue this medication. Patients allergic to any components of this medication, and those with liver disease, muscle disease, severe renal impairment, and women who are pregnant or breastfeeding should not take this medication. Additionally, patients with certain renal impairments, hypothyroidism, a family history of muscle disease, or a history of myotoxicity with other statins, alcoholics, and Asian patients who may be prone to muscle problems should use this medication with caution. This medication contains lactose, so it should not be administered to patients with lactose intolerance or related genetic disorders. Patients with impaired liver function or those who consume excessive alcohol should also exercise caution when using this medication. During the use of this medication, regular liver enzyme tests and muscle-related examinations should be conducted, and it is critical to report any abnormal symptoms to healthcare professionals immediately. This medication may interact with other drugs, so patients should inform their healthcare providers of any medications they are currently taking. Women who are pregnant or planning to become pregnant should not take this medication, and if pregnancy is confirmed during treatment, it should be discontinued immediately. It is also advisable for breastfeeding women not to use this medication. Caution is needed for children and the elderly as the safety and efficacy of this medication have not been sufficiently established. In case of overdose, since there is no specific antidote, treatment should be based on symptoms, and monitoring of liver function and muscle condition is necessary. This medication should be kept out of the reach of children, and it is advisable not to transfer it to another container.

Serious side effects

• Hives, hypersensitivity reactions including angioedema, severe swelling, chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reactions
• Severe rashes with high fever, blistering, skin peeling, mucosal pain in the mouth/eyes, Stevens-Johnson syndrome, eosinophilia, and drug reaction with eosinophilia and systemic symptoms (DRESS), severe skin adverse reactions
• Sudden and severe headaches, lightning headaches, seizures, confusion of consciousness

Mild side effects

• Nasopharyngitis
• indigestion
• myalgia
• headache
• dizziness
• itching
• rash
• weakness
• fatigue
• constipation

This medication may be sensitive to air and moisture, so it should be stored in a tightly closed container. It is best to maintain a storage temperature between 1 degree and 30 degrees Celsius. This helps to maintain the medication's efficacy and safety for a long time.

Appearance

Pink rectangular film-coated tablet

Package unit

30 tablets/box [10 tablets/PTP × 3]